Skip to content
Featured on Startup Fame

BacAlt Biosciences raises ₹18 crore to scale biopolymers from fruit waste

BacAlt Biosciences, a Bengaluru-based startup, ferments agricultural and fruit waste into biopolymers for use in personal care, home care, and other industries. The company raised ₹18 crore (~$2 million) in September 2025 to scale its technology, which aims to replace synthetic polymers with biodegradable alternatives.

Editor, Lazyfounder

Published Updated 3 min read
BacAlt Biosciences raises ₹18 crore to scale biopolymers from fruit waste

30 SEC SUMMARY

  • Bengaluru-based BacAlt Biosciences converts fruit and agricultural waste into biopolymers for use in consumer products.
  • The startup targets formulators needing cost-effective, biodegradable alternatives to synthetic polymers.
  • BacAlt raised ₹18 crore (~$2 million) in September 2025 from Avaana Capital and Lubrizol InnoVentures.
  • Its process avoids sterile fermentation, reducing costs and improving scalability.

KEY HIGHLIGHTS

  • BacAlt Biosciences ferments agricultural and fruit waste into biopolymers like bacterial cellulose and poly-gamma glutamic acid.
  • The company’s product, ReRaw, is marketed as a single biodegradable ingredient replacing multiple synthetic additives.
  • Funding: ₹18 crore (~$2 million) in September 2025, led by Avaana Capital with participation from Lubrizol InnoVentures.
  • BacAlt’s non-sterile fermentation process aims to lower production costs compared to traditional biopolymer methods.

What BacAlt Biosciences does

BacAlt Biosciences converts agricultural residue and agro-industrial fruit waste into two biopolymers: bacterial cellulose and poly-gamma glutamic acid. These are produced through fermentation, using waste as feedstock to reduce input costs and avoid burning crop residue.

The startup’s flagship product, ReRaw, is a blend of these biopolymers. According to BacAlt, ReRaw replaces up to five synthetic additives with a single biodegradable ingredient, offering a cost advantage over existing biopolymers at scale.

The process avoids sterile fermentation, which the company says lowers energy use, reduces production time, and minimizes contamination risks compared to traditional methods.

Who backs the startup

BacAlt raised ₹18 crore (~$2 million) in a funding round announced in September 2025. Avaana Capital led the round, with participation from Lubrizol InnoVentures, the corporate venture arm of American speciality chemicals company Lubrizol.

Lubrizol InnoVentures’ involvement is notable beyond the capital. As a corporate investor from the chemicals industry, it brings formulation expertise and potential distribution channels that financial investors typically lack.

The funds were allocated for research and development, pilot-scale production, hiring, and expanding into new markets.

Markets and timeline

BacAlt’s initial markets are personal care, oral care, and home care, where synthetic polymers are commonly used as thickeners and stabilizers. The company also lists agrochemicals, nutraceuticals, pharmaceuticals, textiles, and wound care as future targets.

At the time of the funding announcement, BacAlt planned to launch its first commercial product in June 2026 from a pre-pilot facility in Bengaluru. Agrochemical and pharmaceutical applications were slated for 2027. However, no launch has been publicly announced as of mid-2026.

The startup was featured at Bharat Innovates in Nice, France, in June 2026, where it sought partnerships. No customers, orders, or revenue figures have been disclosed.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

BacAlt’s approach targets a real pain point for formulators: the need for cost-competitive, biodegradable replacements for synthetic polymers. Regulatory pressure in markets like Europe and North America is pushing consumer goods companies to reformulate products, creating demand for alternatives like ReRaw. The involvement of Lubrizol InnoVentures—a strategic investor with deep industry ties—suggests BacAlt’s technology has been vetted by potential buyers, not just investors. For founders in the biotech or sustainability space, this is a signal that waste-to-value models are gaining traction beyond pilot projects, particularly when they address scalability and cost.

Key takeaways

  • Formulators in personal care, home care, and agrochemicals face regulatory pressure to replace synthetic polymers; BacAlt offers a scalable alternative.
  • Corporate investor Lubrizol InnoVentures signals industry validation and potential distribution partnerships.
  • The startup’s use of waste feedstock could appeal to sustainability-focused buyers and regulators.

Sources

  1. yourstory.com
    How a Bengaluru company turns fruit waste into everyday product ingredients

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author

Editor, Lazyfounder

Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.

More stories by Tarun Mottlia

Get the LazyFounder Brief

Startup, funding and AI news in a five-minute read. Join the early-access list.

Lazy Founder - Powered by Blogy.in

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us